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Transplantation is the optimal treatment for most patients with end-stage kidney 
disease but organ shortage is a major challenge. Normothermic machine perfusion 
(NMP) has been used to recondition marginal organs; however, mechanisms by which 
NMP might benefit organs are not well understood. Using pairs of human kidneys ob-
tained from the same donor, we compared the effect of NMP with that of cold storage 
on the global kidney transcriptome. We found that cold storage led to a global reduc-
tion in gene expression, including inflammatory pathway genes and those required 
for energy generation processes, such as oxidative phosphorylation (OXPHOS). In 
contrast, during NMP, there was marked upregulation OXPHOS genes, but also of 
a number of immune and inflammatory pathway genes. Using biopsies from kidneys 
undergoing NMP that were subsequently transplanted, we found that higher inflam-
matory gene expression occurred in organs with prolonged delayed graft function 
(DGF). Therefore, we used a hemoadsorber (HA) to remove pro-inflammatory cy-
tokines. This attenuated inflammatory gene expression increased OXPHOS pathway 
genes and had potentially clinically important effects in reducing the expression of a 
DGF-associated gene signature. Together, our data suggest that adsorption of pro-
inflammatory mediators from the perfusate represents a potential intervention which 
may improve organ viability.
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1  |  INTRODUC TION
Kidney transplantation represents the optimal treatment for most 
patients with end-stage kidney disease, with benefits for both qual-
ity and quantity of life.1 Organ shortage is a major challenge, and 
several strategies have been employed to increase the number of 
kidneys available, including the use of deceased circulatory death 
(DCD) donors and extended criteria donors (ECD), both of which are 
associated with higher rates of delayed graft function (DGF) com-
pared with deceased brainstem death (DBD) donor.2,3 In DCD kid-
neys, exposure to warm ischemia during the process of circulatory 
cessation makes a significant contribution to DGF. DGF occurs due 
to ischemic tubular cell damage or death, which can stimulate innate 
immune activation via NLRP3 inflammasome assembly leading to 
the generation of interleukin (IL)1β and IL18.4-6 Indeed, the presence 
of inflammatory cytokines in urine has been used as a biomarker of 
acute kidney injury and DGF.7-9
Normothermic machine perfusion (NMP) allows transplanted 
organs to be perfused with warm, oxygenated red blood cells, in 
the absence of circulating immune components, including com-
plement and neutrophils.10-14 This process has been used to as-
sess marginal organs15 and to “recondition” organs to facilitate 
the transplantation of kidneys that were initially declined fol-
lowing offer via national organ allocation service.16 Our previous 
experience using NMP provided the rationale for a randomized 
controlled trial to assess its efficacy in preventing DGF in DCD 
kidneys,17 but the mechanisms by which NMP might benefit trans-
plant kidneys are not fully understood. Furthermore, the question 
of whether additional manipulation of the kidney during NMP, for 
example by removal of pro-inflammatory cytokines and chemok-
ines from the perfusate, might offer additional benefits in opti-
mizing the organ prior to transplantation has not been addressed 
in human kidneys, but our study of porcine NMP demonstrated 
promising results.18
Here we took an unbiased approach to address these two ques-
tions using transcriptomic analysis of human kidney biopsies taken 
at the start and end of NMP to assess global changes in gene expres-
sion. We used pairs of human kidneys from a single donor enabling a 
comparison of the effect of different interventions in organs with an 
identical genetic background and were able to assess the impact of 
those changes on a prediction of graft outcome.
2  |  RESULTS
2.1  |  Paired kidneys are genetically similar and a 
useful model for assessing interventions
We investigated the transcriptional changes associated with organ 
preservation and NMP in two independent studies, each with five 
pairs of kidneys, making a total of 10 pairs/20 human kidneys. Of 
these, two were from DBD and eight from DCD donors (Table S1, S2 
and Figure S1). In these studies, we took cortical biopsies pre- and 
postintervention (cold storage or NMP) and investigated the tran-
scriptional landscape using RNA sequencing (RNA-Seq). The use of 
paired kidneys and paired biopsies from the same kidney allowed us 
to control for biological variation and to regress this confounder out 
of the analysis (Figure S2A). We confirmed that kidney pairs start 
with a common transcriptional landscape (Fig. S2B) and by applying 
different interventions to each kidney in a pair, we are able to study 
the effect of an intervention independent of biological variation.
2.2  |  NMP results in an increase in OXPHOS and 
inflammatory pathway genes compared with 
cold storage
To investigate the potential mechanisms by which NMP might im-
pact kidneys, we initially took five kidney pairs (n = 4 DCD do-
nors and n = 1 deceased brainstem death [DBD] donor, Figure S1, 
Table S1) and performed a time 0 (0 hour) cortical biopsy. At this 
point, the kidneys were randomized to static cold storage or NMP, 
as described previously 10 (Figure 1A). After 2 hours, a second bi-
opsy was taken from both kidneys and RNA-Seq performed. When 
comparing gene expression between the time 0- and 2-hour biop-
sies, we found that kidneys placed in static cold storage had no 
statistically significant change in the expression of any individual 
gene when corrected for multiple testing (Figure 1B, left panel). 
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F I G U R E  1  Kidneys exposed to cold storage show limited changes in gene expression compared with those undergoing NMP. A, Pairs 
of kidneys were obtained which had been declined for use in transplantation. One kidney was maintained in static cold storage and the 
other underwent normothermic machine perfusion (NMP). Biopsies were taken from the outer cortex at the start and after 2 hours. B, 
Volcano plot indicating change in gene expression at 2 hours for the indicated group compared to the start. Red dots indicate differentially 
expressed genes with an adjusted P value <0.05 and the experimental group is indicated above the plot. C, Gene set enrichment analyses 
of the differential expressions from B against the hallmarks pathways. Only significant pathways (FDR q value <0.05) are plotted. Red dots 
indicate positive enrichment and blue negative, the size of the dot is inversely correlated with the FDR q value and the position indicates the 
normalized enrichment score (NES). D, Heatmap of the top 20 significantly upregulated genes during NMP, genes are ranked by log2 fold 
change. E, STRING analysis of the top 50 genes upregulated during NMP. The color of each node indicates membership of each cluster
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In contrast, during the course of 2 hours of NMP, 956 genes were 
upregulated and 353 genes were downregulated (Figure 1B, right 
panel). We next assessed changes in the expression of groups of 
genes within a common pathway, comparing tens or hundreds of 
genes rather than any individual gene, thereby further reducing the 
effect of biological interindividual variation on the analysis. This 
revealed changes in functionally important pathways, where the 
expression of each individual gene within that pathway was not 
altered with sufficient magnitude to reach statistical significance. 
This gene set enrichment analysis (GSEA) demonstrated that cold 
storage had a substantial impact on a number of metabolic path-
ways (Figure 1C, left panel). In particular, there was a marked re-
duction in genes involved in oxidative phosphorylation (OXPHOS), 
a key pathway required to generate ATP.19 In contrast, OXPHOS 
was among the pathways significantly upregulated during NMP 
(Figure 1C, right panel), with potential benefits for cell viability 
and the restoration of cellular homeostasis. In addition, a number 
of pathways involved in immune or inflammatory processes were 
induced during NMP, with “TNFα signaling via NFkB” demonstrat-
ing the largest increase. In keeping with this, TNF as well as IL1B 
and the neutrophil-recruiting chemokines CXCL8 (IL8) and CXCL2 
were among the most upregulated genes in 2-hour NMP biop-
sies (Figure 1D). String analysis of the top 50 upregulated genes 
revealed upregulation of biochemically related genes which were 
clustered into four major nodes; IL8 and neutrophil-recruiting 
chemokines, Inflammasome-associated genes, NFkB signaling, and 
transcriptional regulation (Figure 1E). Of note, DBD and DCD kid-
neys were transcriptionally similar at baseline (Figure S2C), and the 
gene pathways changing during NMP were similar in DBD and DCD 
kidneys (Figure S2D). Together, our analysis demonstrates that dur-
ing NMP, there is an increased expression of genes that promote 
the generation of energy, with potentially beneficial effects for the 
organ, but a simultaneous induction of pro-inflammatory genes, 
which may be deleterious.
F I G U R E  2  Correlation of transcriptome following NMP with the length of delayed graft function. A, Gene expression was correlated with 
the length of DGF in biopsies taken following NMP as part of a randomized clinical trial. The expression levels of the 1000 genes with the 
greatest correlation with outcome have been plotted. B, GSEA was performed for the correlation from A against the hallmarks data set. Only 
significant pathways (FDR q value <0.05) are plotted. Red dots indicate positive enrichment and blue negative, the size of the dot is inversely 
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2.3  |  Inflammatory pathway genes in NMP kidneys 
associated with prolonged delayed graft function
In order to link the transcriptional changes occurring during cold 
storage and NMP to clinical outcomes, we performed RNA-Seq 
on biopsies taken from 33 DCD kidneys that had undergone NMP 
as part of a randomized clinical trial currently assessing its effi-
cacy.17 Samples were available on a subset of kidneys randomized 
to the NMP arm of the study that were subsequently transplanted 
(Table S3, Figure S1). DGF is more common in DCD kidneys and is 
F I G U R E  3  Correlation of transcriptome of NMP after 2 hours with perfusion parameters. A, left panel, Total urine output by each 
kidney after 2 hours of normothermic machine perfusion (NMP). Right panel, Heatmap of all genes that are significantly correlated with 
urine output in biopsies taken post-NMP. B, Enrichment plots from GSEA for key pathways from the Hallmark database. Analysis is for the 
correlation of urine output after 2 hours with the transcriptome of the kidney either pre–(0-hr) or post–2-hr NMP. The line indicates the 
running enrichment score and the violin plot indicates the distribution of the member genes of the geneset throughout the ranked gene list 
used in each analysis. C, left panel, Renal blood flow after 2 hours of NMP. Right panel, Heatmap of all genes which significantly correlate 
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classically defined as a requirement for dialysis in the first week 
posttransplant. However, in the immediate posttransplant period, 
some patients receive a single episode of dialysis for hyperkalemia, 
which does not necessarily reflect the presence of significant acute 
tubular necrosis. We therefore used a model correlating gene ex-
pression with time between transplant surgery and the last dialysis 
session (ie, duration of DGF). This showed more marked transcrip-
tional changes in transplants requiring dialysis beyond the first 24 
hours of posttransplant (Figure 2A), as well as a significant positive 
correlation between the expression of inflammatory pathway genes 
including “TNFA signaling via NFkB” and “inflammatory response” 
pathways and the length of DGF, with a greater enrichment of 
these pathways in kidneys that experienced more prolonged DGF 
posttransplant (Figure 2B). Conversely, the length of DGF nega-
tively correlated with the magnitude of expression of “OXPHOS” 
pathway genes (Figure 2B). Taken, together these data indicate that 
following NMP, kidneys that have lower expression of inflamma-
tory pathway genes and higher expression of “OXPHOS” pathway 
genes are less susceptible to prolonged DGF posttransplant. This 
would support the conclusion that the molecular changes occurring 
during NMP may have both beneficial (induction of OXPHOS path-
way genes) and deleterious (induction of inflammatory pathways 
genes) effects.
2.4  |  Urine output and renal blood flow during 
NMP demonstrate differing associations with 
OXPHOS and inflammatory pathway genes
The quantity of urine produced during NMP is one of a number 
of parameters included in surgical quality assessment scores used 
to guide organ utilization decisions,15 but whether high urine out-
put during NMP truly portends a good prognosis for the kidney 
and the underlying molecular pathways activated in kidneys with 
a high urine output is unclear. In a total of 10 kidneys undergoing 
NMP (NMP only kidneys, Table S1 and S2, Figure S1), we observed 
a range of urine outputs from 0 to 340 ml over the 2-hour period of 
perfusion (Figure 3A left panel). Of note, when we compared the 
pathways changing during NMP in five kidneys in two independent 
experiments, we found that similar pathways were induced (Figure 
S3A) confirming the reproducibility of our experimental design and 
the utility of comparing pathways rather than individual genes. In 
the 2-hour postperfusion biopsies, the expression of 11 genes sig-
nificantly correlated with the urine volume produced during this pe-
riod. These included heat shock proteins (HSPs), HSPA1A, HSPA1B, 
and HSPH1, which positively correlated with increased urine out-
put (Figure 3A right panel). Gene set enrichment analysis showed 
that urine output also positively correlated with the “TNFα signaling 
via NFkB” pathway genes, and negatively correlated with OXPHOS 
genes in postperfusion biopsies (Figure 3B, S3C). Similarly, in prep-
erfusion biopsies, OXPHOS negatively correlated with urine output 
in these kidneys while pathways associated with immune activation 
including “TNFα signaling via NFkB” and “allograft rejection” posi-
tively correlated with urine output, suggesting that NMP had little 
effect on these processes, or on other pathways analyzed, in high 
urine output kidneys (Figure 3B, S3C-D). Since the induction of 
inflammatory pathway genes was observed in our clinical samples 
with prolonged DGF (Figure 2B), these data challenge the dogma 
that high urine output occurs in more viable, “healthy” kidneys and 
suggest that in fact these kidneys may have more inflammatory po-
tential, are less able to generate energy, and that this is not substan-
tially altered during NMP.
Renal blood flow during perfusion has also been assessed as 
a parameter that may reflect subsequent transplant function.15 In 
the 10 kidneys studied, renal blood flow at 2 hours of perfusion 
varied from 14.1 to 168.8 ml/minute (Figure 3C left panel). In the 
2-hour postperfusion biopsies, eight genes significantly positively 
correlated with increasing renal blood flow (Figure 3C right panel), 
including HSPA1L, but there was no direct overlap between this 
gene list and those correlating with urine output (Figure 3A). Gene 
set enrichment analysis demonstrated that high renal blood flow 
positively correlated with OXPHOS genes in 0-hour biopsies, but in 
contrast to those with the highest urine output, perfusion had a sig-
nificant impact, resulting in a negative correlation with “OXPHOS” 
pathway genes by 2 hours (Figure 3D, Figure S4A-B). Renal blood 
flow negatively correlated with a number of immune and inflam-
matory gene pathways in both 0- and 2-hour biopsies (Figure 3D, 
Figure S4B), in contrast to urine output (Figure 3B, Figure S3C). 
Together these data suggest that renal blood flow and urine output 
may not be equivalent indicators of a more viable kidney, but that 
the former may more faithfully identify a kidney less likely to have 
prolonged DGF.
F I G U R E  4  Addition of a hemoadsorber to the normothermic machine perfusion circuit has substantial effects on cytokine level in 
perfusate and the transcriptome but not on physical parameters recorded on the rig. A, Pairs of human kidneys were taken from the 
same donor, one of the pair underwent the standard normothermic machine perfusion (NMP) protocol for 4 hours and the other kidney 
underwent NMP with the addition of a hemoadsorber to the circuit. Samples were taken for RNA-Seq prior to perfusion (0 hour), after 
2 hours, and at the end (4 hours). B, Concentration of key cytokines in the perfusate after 4 hours of NMP. Line indicates pairs of kidneys. 
Cytokine measurements were normalized to total perfusate protein content. P value stated is from a paired t test testing for the reduction of 
cytokines with addition of HA. C, Urine production and renal blood flow (RBF) across the time course of perfusion. Green line indicates NMP 
alone and orange with the addition of hemoadsorber. D, Venn diagram showing the numbers of genes significantly differently expressed 
when comparing the 2-hr or the 4-hr samples to the pre(0-hr) samples. Red diagrams are upregulated genes and blue downregulated. The 
intersection are the genes which are deferentially expressed at both time points in the same direction. E, log2 normalized expression values 
for the indicated genes across perfusion from the tissue transcriptome, standard error bars are indicated. F, Volcano plot for pairwise 
comparison of NMP alone with NMP +HA at 4 hours. Red indicate differentially expressed genes with adjusted P value <0.05. G, As for E
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2.5  |  Addition of a hemoadsorber to the perfusion 
circuit has no effect on perfusion parameters but 
significantly reduces inflammatory gene expression, 
including NLRP3 and IL1B
Analyses of kidney perfusate have demonstrated a substantial in-
crease in the concentration of pro-inflammatory cytokines and 
chemokines during the course of hypothermic and NMP.20,21 These 
bioactive molecules recirculate into the kidney, with the potential to 
induce further inflammation. Given that our analysis of transplanted 
kidney samples indicated that the induction of TNF-dependent 
genes in NMP kidneys was associated with DGF (Figure 2B), we 
hypothesized that removal of cytokines and chemokines from 
the perfusion circuit may attenuate inflammatory gene induction, 
with potential beneficial effects for the kidney. Such an approach 
has shown some efficacy in patients with systemic inflammatory 
response syndrome,22,23 and was associated with increased renal 
blood flow in porcine kidneys undergoing NMP.18 To test this in 
human kidneys, we took an additional five kidney pairs and per-
formed NMP for 4 hours with biopsies taken at 0, 2, and 4 hours 
(Figure S1). In each case, a cytosorb hemoadsorber (HA) that re-
moves molecules with a molecular weight of 10-50 kDa was added 
to the perfusion circuit of one kidney within each pair (NMP+HA) 
(Figure 4A). As anticipated, the addition of the HA resulted in lower 
concentrations of a variety of cytokines in the perfusate (Figure 4B) 
but had no effect on renal blood flow, urine output or composition, 
oxygen consumption, and acid–base homeostasis (Figure 4C, Table 
S4, S5). Thus, over 4 hours of NMP, the HA had no impact on the 
perfusion parameters currently used clinically to generate quality 
assessment scores but had a substantial effect on gene expression; 
Following NMP, 1794 and 4026 genes were upregulated at 2 and 
4 hours, respectively, including TNF and IL6 (Figure 4D,E). but only 
half this number (n = 898 and n = 2606) were increased when the 
HA was present (Figure 4D, Figure S5A and B). The number of genes 
downregulated was also reduced by the addition of HA (Figure 4D). 
After 4 hours of NMP, 46 genes were significantly upregulated and 
181 downregulated with the addition of the HA (Figure 4F). This 
attenuated transcriptional response included NLRP3 inflamma-
some activation-associated genes, such as IL1B, NLRP3, and CASP1 
(Figure 4G, Figure S4B) and some neutrophil-recruiting chemokines 
(Figure S5C), previously associated with kidney injury in animal 
models.24,25 This demonstrates that soluble mediators released 
from the kidney recirculate and drive de novo expression of inflam-
matory genes within the organ, but that this can be alleviated by 
their removal from the perfusion circuit.
2.6  |  HA associated with a reduction in a delayed 
graft function–associated gene signature
Gene set enrichment analysis showed a significant decrease in the 
“TNFα signaling via NFkB” pathway in NMP+HA kidneys compared 
with NMP alone (Figure 5A-B). Notably, the presence of the HA not 
only reduced inflammatory gene expression within the kidney but 
also increased OXPHOS and fatty acid metabolism pathways, both 
of which contribute to energy generation (Figure 5A-B). Therefore, 
the changes in gene expression pathways occurring with the HA 
would support the conclusion that its effects are clinically benefi-
cial, since it reduced “TNFA signaling via NFkB” pathway genes and 
increased “OXPHOS” pathway genes, both of which were associated 
with a shorter duration of DGF (Figure 2B).
To further explore the relationship between transcriptional 
changes in NMP and clinical outcomes, we sought to curate a gene 
signature present in kidneys with DGF. We identified the top 100 
positively (UP) and negatively (DOWN) regulated genes (ranked by 
log fold change) which correlated with the length of DGF in the 33 
clinical trial samples (Figure 5C, Data S1). We found a significant 
enrichment of the gene signature associated with increased length 
of DGF in samples with a higher urine output (Figure 5D), suggest-
ing that high urine output during NMP identifies kidneys at risk 
of more prolonged DGF. There was no statistically significant cor-
relation between the DGF signature and the genes associated with 
higher renal blood flow (Figure 5E). We next assessed whether and 
how the addition of the HA to the NMP circuit affected the ex-
pression of DGF “UP” and “DOWN” gene signatures. Remarkably, 
this showed that the expression of the gene signature associated 
with increased length of DGF was significantly reduced by the 
addition of the HA, and the signature associated with decreased 
length of DGF was significantly increased by the addition of the 
HA (Figure 5F).
Overall, the transcriptional changes we have identified sug-
gest that NMP has potential benefits over cold storage in terms 
of its effects on energy generation in the kidney. However, during 
perfusion, some bioactive molecules are released from the kidney 
F I G U R E  5  Addition of the hamadsorber reduces a DGF-associated gene signature. A, GSEA analysis of the effect of the addition of 
HA to the transcriptome after 4 hours NMP against the hallmarks pathway of genesets. Only significant pathways are plotted. Red dots 
indicate positive enrichment and blue negative, the size of the dot is inversely correlated with the FDR q value and the position indicates 
the normalized enrichment score (NES). B, Enrichment plots from GSEA for key pathways from the Hallmark database for the comparison 
from A. The line indicates the running enrichment score and the violin plot indicates the distribution of the member genes of the geneset 
throughout the ranked gene list used in each analysis. C, Heatmap of the top four greatest positive (UP) and negative (DOWN) correlation 
with length of DGF and used as part of the gene expression signature for DGF. Full DGF signature given in supplemental data. D-F, DGF-
associated gene signature was used with GSEA to investigate the expression of the signature in the correlation of 2-hr urine output with 2-hr 
transcriptome (D), correlation of 2-hr RBF with 2-hr transcriptome (E) and the effect of addition of HA on the transcriptome at 4 hours (F). 
Plots as for A
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into the perfusion circuit, generating an amplification loop that 
drives inflammation when they reenter the kidney. Removal of 
these molecules interrupts this loop, and may be useful to reduce 
inflammation and increase energy generation, further enhancing 
the beneficial effects of NMP and reducing susceptibility to DGF 
(Figure 6).
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3  |  DISCUSSION
Our data show that cold storage is effective in limiting substantial 
changes in gene expression. This is in keeping with rodent models, 
where kidneys stored for up to 18 hours in cold storage showed 
little change in the expression of pro-inflammatory cytokines, in-
cluding IL1β, TNF, and IL6.26 Our use of unbiased, global transcrip-
tional profiling rather than the measurement of a small number of 
candidate genes allowed us to analyze the expression of groups of 
genes found within specific pathways. This revealed a significant 
reduction in the expression of OXPHOS and glycolysis pathway 
genes in cold stored kidneys, potentially reducing the capacity of 
these kidneys to generate ATP, in line with a previous study show-
ing reduced ATP in cold stored human kidneys.27 A number of 
pro-inflammatory pathways were also downregulated during cold 
storage, including TNFα activation via NFkB and reactive oxygen 
species pathways which may be potentially beneficial. However, 
it may be that cold storage merely puts a temporary hold on these 
pathways, and that following reperfusion in the recipient, similar 
changes in inflammatory gene expression as observed in NMP 
would occur.
NMP had the opposite effect to cold storage on OXPHOS and 
glycolysis pathway genes, increasing their expression, with the 
potential to increase the cellular capacity to generate ATP and 
to restore homeostasis. Of note, hypothermic oxygenated perfu-
sion of human kidneys has also been shown to increase ATP levels 
compared with cold storage 27, therefore the restoration of oxy-
genation may be the principle stimulus for these processes rather 
than normothermia. Nonetheless, these changes are likely to be 
beneficial to the organ given our observation of a negative correla-
tion between increased expression of OXPHOS pathway genes and 
prolonged DGF.
A recent paper by Hameed et al28 also performed transcriptomic 
analysis of NMP in three kidneys undergoing NMP. Unfortunately, 
the authors did not made their data publicly available, thus an in-
depth comparison with our dataset is not possible. However, their 
manuscript indicated an induction of immune response-related 
genes during NMP, including IL1B, CXCL2, and TNF, which is con-
cordant with our findings.
In our analysis of kidneys undergoing NMP in the context of a 
clinical trial, we correlated gene expression signatures with length 
of DGF rather than DGF incidence (defined as a need for dialysis 
within the first week posttransplant). Notably, kidneys with a du-
ration of DGF of 1 day or less were highly transcriptionally similar 
to those with no DGF, likely reflecting dialysis requirement due to 
peri-operative-associated hyperkalemia rather than bona fide DGF. 
We found that a longer DGF was associated with higher expression 
of TNFA signaling via NFkB pathway genes and lower expression of 
genes associated with OXPHOS. These data suggest that kidneys 
with increased OXPHOS and decreased immune signaling may pres-
ent better potential as donor kidneys, but this conclusion requires 
validation in a larger prospective study.
F I G U R E  6  Graphical summary. A, During cold storage, there is a global reduction in transcription. During NMP the expression of genes 
in a number of pathways are upregulated including oxidative phosphorylation (OXPHOS) and inflammatory pathway genes such as TNF, 
IL8, and NFkB. B, left panel, During NMP, inflammatory mediators (yellow circles) are released from the kidney into the perfusion solution. 
They recirculate and stimulate pro-inflammatory gene transcription in the kidney, and are associated with a reduction in energy pathway 
production genes, reducing ATP. Right panel, The presence of the hemoadorber (HA) breaks this inflammatory amplification loop
A B
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We also assessed the molecular processes that correlate with 
urine output and renal blood during NMP. These parameters have 
previously been used, along with a number of other measures, to 
generate a quality assessment score of perfused kidneys. High val-
ues of urine output and renal blood flow have been considered to re-
flect a more viable graft.15 Our data reveal that pathways correlating 
with high urine output and high renal blood flow differ, and in fact, 
these parameters demonstrate polar opposite associations with in-
flammatory pathways. High urine output was associated with higher 
expression of immune pathway genes while high renal blood flow 
was negatively correlated with these pathways. We also found that 
the DGF gene signature we generated was enriched in kidneys with 
a high urine output during NMP, suggesting that this parameter may 
identify kidneys at risk of a longer DGF, in contrast to the current 
dogma. One potential explanation is that a very high urine output 
reflects kidneys with more tubular damage that lack the capability 
to concentrate urine. Thus, there may be a “Goldilocks effect” with 
regard to urine output, where kidneys with low/little urine output 
are those with substantial abnormalities in the generation of filtrate, 
those with a very high urine output have substantial tubular dam-
age precluding urine concentration. This hypothesis would need 
to be tested in a larger number of kidneys that were subsequently 
transplanted.
During 4 hours of NMP, there was an induction of inflammatory 
genes in the kidney. However, it is worth noting that current clinical 
practice involves 1 hour of NMP only, and this effect may not be 
evident over a shorter perfusion time. However, longer perfusion 
may have benefits in terms of restoration of oxygenation and energy 
generation, and in our experiment, the negative effects of immune 
gene induction could be substantially negated by the introduction 
of a cytosorb HA to the perfusion circuit. These data indicate that 
inflammatory mediators generated by the kidney during the course 
of NMP enter the perfusion circuit and are capable of exacerbat-
ing sterile inflammation, and that their removal ameliorates the 
induction of inflammation pathway genes observed during NMP. 
Importantly, we showed that the addition of the HA affects the ex-
pression of genes that are associated with worse outcomes clinically. 
Our DGF gene signature was derived from samples undergoing NMP 
as part of a clinical trial assessing its efficacy, allowing us to robustly 
link the changes we observed in our paired kidney studies with clin-
ical endpoints in kidneys undergoing transplant. However, its appli-
cation in the context of a clinical trial will be needed to definitively 
prove the utility of its application to kidneys pretransplant. The HA 
is nonspecific and may remove molecules which are helpful, in addi-
tion to those which are detrimental to the organ. We found that the 
net effect of the HA on the kidney transcriptome appeared benefi-
cial, but it may be that a refinement to specifically remove proven, 
deleterious mediators may be even more effective.
The kidney pairs we used were from the same individual and 
were therefore genetically identical and had experienced a similar 
environment throughout the life of the donor. We confirmed that 
their time 0 transcriptome was extremely similar (Figure S2 A,B). 
However, these biopsies sample a small part of the kidney, and 
kidney pairs could be asymmetrically affected by pathology, for ex-
ample, cysts, or small vessel disease. An additional caveat is that all 
kidneys used in the intervention experiments presented here were 
declined for transplantation and some represent transplanted or-
gans at the lower end of the quality spectrum. Nevertheless, we ob-
served highly reproducible results when comparing gene pathways 
in groups of five kidneys. We were also able to demonstrate that 
kidneys from DCD and DBD had a similar response to perfusion. 
By combining this with our curated post-NMP DGF signature, we 
were able to predict potential clinical benefits. This experimental 
approach could be employed as a preclinical tool to screen future in-
terventions for potential therapeutic efficacy to enable the rational 
selection of candidate interventions for clinical trials.
In summary, our study provides the first global transcriptional 
profile of human kidneys undergoing NMP, resolving the differing 
molecular pathways that are activated in NMP compared with cold 
storage, and showing that the deleterious effects of bioactive mol-
ecules produced or released from the kidney during NMP can be 
reversed by the addition of a HA. Furthermore, this intervention 
reduced the expression of genes associated with prolonged DGF 
providing a strong mechanistic rationale for applying such an inter-
vention to a future clinical trial. Our data also have implications for 
perfusion strategies beyond the kidney, including in liver and lung 
transplantation, suggesting that the removal of bioactive molecules 
from perfusates should be investigated in these contexts where 
NMP is increasingly used. Finally, our study highlights the utility of 
global transcriptional profiling in paired kidneys for assessing novel 
interventions to perfused organs; transcriptional changes precede 
changes in protein abundance (traditionally used as biomarkers of 
kidney injury) and tens of thousands of gene transcripts can be read-
ily measured. Thus, RNA measurement has the potential to provide 
an early, sensitive readout of cellular function of human organs re-
trieved for transplantation that can be applied to future studies.
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